HITI
High Tide Inc.
HITI has the edge over NVO overall, supported by stronger fundamentals and lower modeled downside.
NVO
Novo Nordisk A/S
NVO offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
HITI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Under pressure | |
| Weak |
HITI's revenue is currently strong, but its profitability, cash flow and balance sheet are under pressure.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
HITI PE Valuation
HITI has no meaningful PE right now: it lost money over the past year.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
HITI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
HITI has the edge over NVO on the outlook, with more favorable earnings and profitability expectations.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
HITI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.27 | -$0.22 |
| Q2 2026 | -$0.35 | -$0.30 |
| Q1 2026 | -$0.38 | -$0.36 |
| Q4 2025 | -$0.41 | -$0.41 |
| Q4 2024 | -$0.00 | +$0.37 |
| Q4 2023 | -$0.37 | +$0.38 |
| Q3 2023 | -$0.60 | -$0.31 |
| Q2 2023 | -$0.60 | -$0.32 |
HITI is still losing money, but far less than before: $0.27 per share over the past year, against $1.38 at its worst in early 2020.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over HITI on earnings quality, reporting a profit while its opponent remains loss making.
HITI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $141.3M | +34% |
| Q2 2026 | $126.1M | +30% |
| Q1 2026 | $125.6M | +25% |
| Q4 2025 | $115.3M | +19% |
| Q3 2025 | $105.2M | +14% |
| Q2 2025 | $96.9M | +11% |
| Q1 2025 | $100.2M | +11% |
| Q4 2024 | $97.2M | +8.8% |
HITI's revenue has grown year over year every quarter since early 2021: $141M last quarter, up 34% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.3% | +1.8 points |
| Q2 2026 | 4.5% | +3.8 points |
| Q1 2026 | 2.3% | +2.3 points |
| Q4 2025 | -12% | -9.6 points |
| Q3 2025 | 2.5% | +0.2 points |
| Q2 2025 | 0.7% | -0.9 points |
| Q1 2025 | 0.1% | -2.1 points |
| Q4 2024 | -2% | N/A |
HITI's operating margin was 4.3% last quarter, up 1.8 points from the same quarter a year ago.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over HITI on profitability, with a higher operating margin.
HITI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.5M | +10% |
| Q2 2026 | $1.6M | -59% |
| Q1 2026 | $2.2M | +$3.7M |
| Q4 2025 | $812.7K | -85% |
| Q3 2025 | $5.9M | +206% |
| Q2 2025 | $4M | -46% |
| Q1 2025 | -$1.4M | -143% |
| Q4 2024 | $5.4M | +2.4% |
HITI still generates free cash flow, though less than at its 2024 peak: $11M over the past year.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over HITI on cash flow, with more consistent year-over-year improvement.
HITI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.6% | +6.7M shares |
| 1 year | +6.8% | +6M shares |
| 3 years | +26% | +19.6M shares |
| 5 years | +96% | +46.2M shares |
| Available history | +672% | +82.3M shares |
HITI has 95M diluted shares, up 6.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
HITI hasn't bought back shares in the past year.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over HITI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
HITI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 17.4x | High |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 1.0x | Healthy |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 0.8x | Very low |
| Q3 2022 | 5.6x | High |
| Q2 2022 | 5.1x | High |
| Q1 2022 | 7.5x | High |
HITI's net debt is about 17 years of its operating earnings (EBITDA), up from less than a year a year ago.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO has the edge over HITI on leverage, with a lower net debt burden relative to earnings.
HITI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.0 | Neutral |
| Stochastic | 59.7 | Neutral |
HITI's weekly RSI is 50 (neutral) and its Stochastic is 60 (neutral).
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
HITI PE vs Healthcare Sector
HITI has no meaningful PE right now: it lost money over the past year.
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
HITI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.61 | 4.2% below |
| 20 week MA | $2.46 | 1.6% above |
| 50 week MA | $2.46 | 1.6% above |
| 100 week MA | $2.59 | 3.5% below |
| 200 week MA | $2.20 | 14% above |
HITI has the edge over NVO on trend strength, trading above more of its moving averages.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 50% below its 200-week average.
HITI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $3.15 | $4.70 | +49% |
| 2022 | $4.70 | $1.43 | -70% |
| 2023 | $1.43 | $1.63 | +14% |
| 2024 | $1.63 | $3.05 | +87% |
| 2025 | $3.05 | $2.78 | -8.9% |
| 2026 YTD | $2.78 | $2.50 | -10% |
HITI has the edge over NVO on returns for 2026, with the stronger performance.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has finished higher in four of the last six years, two of them by more than 50%. It's down 22% so far in 2026.